Bayer reported 7.14B in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Akzo Nobel AKZA:NA 1.03B 52M
Alcon AG ALC:SW 1.19B 22.42M
Amarin AMRN:US $ 58.63M 13.76M
Arkema AKE:FP € 834M 82M
Artemis Alpha ATS:LN -2637000000 1.64B
AstraZeneca AZN:LN 728.3B 34.55B
BASF BAS:GR 5.84B 162M
Bayer BAYN:GR 7.14B 2.32B
Covestro 1COV:GR 920M 266M
Essilor EI:FP 7.61B 808M
Fresenius FRE:GR € 2678M 120M
Fresenius Medical Care FME:GR € 1346M 87.9M
Givaudan GIVN:VX 1.46B 84M
GlaxoSmithKline GSK:LN 479.3B 29.3B
Hikma Pharmaceutical HIK:LN 51.17B 538.95M
Johnson Matthey JMAT:LN 50.6B 4.2B
Linde LIN:GR 3.52B 104M
Lonza Group LONN:SW 1.2B 129M
Merck MRK:GR € 3459M 248M
Novartis NOVN:VX 9.34B 277M
Nutrien Ltd NTR:CN C$ 6B 2.74B
Philips PHIA:NA € 1732M 221M
Ppg Industries PPG:US $ 1737M 127M
SAP SAP:GR 5.37B 341M
Solvay SOLB:BB € 1069M 180M
Umicore UMI:BB 835M 193.75M